Winner Total Stockholder Equity from 2010 to 2024

300888 Stock   40.38  3.18  8.55%   
Winner Medical's Total Stockholder Equity is increasing over the years with slightly volatile fluctuation. Total Stockholder Equity is expected to dwindle to about 7.4 B. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
11.5 B
Current Value
7.4 B
Quarterly Volatility
4.2 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Winner Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Winner Medical's main balance sheet or income statement drivers, such as Tax Provision of 222.6 M, Net Interest Income of 73 M or Interest Income of 140.6 M, as well as many indicators such as . Winner financial statements analysis is a perfect complement when working with Winner Medical Valuation or Volatility modules.
  
This module can also supplement various Winner Medical Technical models . Check out the analysis of Winner Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Winner Stock

Winner Medical financial ratios help investors to determine whether Winner Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Winner with respect to the benefits of owning Winner Medical security.